FDA-Albuterol Inhalers: Making the Switch from CFCs

FDA Consumer Corner
July 2008
FDA Patient Safety News

Albuterol Inhalers: Making the Switch from CFCs

Millions of people use albuterol inhalers to help treat the wheezing that occurs with asthma, emphysema and other airway diseases. These inhalers have traditionally used propellants called CFCs (chlorofluorocarbons) to help push albuterol into the lungs. But that's changing.

Because CFCs damage the atmosphere's ozone layer, inhalers that use this ingredient won't be available after December 31, 2008 due to an international agreement to help protect the environment. Under this agreement, the United States and most other countries have agreed to phase out CFCs and other ozone-depleting substances.

To view the complete press release: (Original press release no longer available)

News

• Overview
• News Archive
• Press Releases

Share This Page

 

We need your support

The American Latex Allergy Association depends on your membership dues and contributions to provide services to individuals and professionals.

Latest Healthcare Guide